Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 22:57 | 2026-06-12 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | Officer | OPT+S | $69.72 | 9,854 | $687,035 | 16,899 |
| 2026-06-15 22:57 | 2026-06-11 | PBLS | Parabilis Medicines, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | BUY | $20.00 | 21,188,750 | $423,775,000 | 2,648,278 |
| 2026-06-15 22:35 | 2026-05-11 | LYEL | Lyell Immunopharma, Inc. | Lee Gary K. | Officer | SELL | $18.92 | 130 | $2,460 | 17,808 |
| 2026-06-15 22:37 | 2026-05-11 | LYEL | Lyell Immunopharma, Inc. | Seely Lynn | Director, Officer | SELL | $18.91 | 388 | $7,337 | 73,878 |
| 2026-06-15 22:44 | 2026-06-12 | ANIP | ANI PHARMACEUTICALS INC | Cook Meredith | Officer | SELL | $82.03 | 500 | $41,015 | 77,890 |
| 2026-06-15 22:46 | 2026-06-15 | RARE | Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman | Officer | SELL | $24.62 | 1,899 | $46,753 | 94,462 |
| 2026-06-15 22:32 | 2026-05-11 | LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | Officer | SELL | $18.91 | 217 | $4,103 | 15,420 |
| 2026-06-15 22:34 | 2026-05-11 | LYEL | Lyell Immunopharma, Inc. | Hill Stephen J. | Officer | SELL | $18.92 | 89 | $1,684 | 17,894 |
| 2026-06-15 21:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | OYLER JOHN | Director, Officer | SELL | $257.24 | 1,949 | $501,355 | 0 |
| 2026-06-15 21:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | Officer | SELL | $257.64 | 428 | $110,268 | 0 |
| 2026-06-15 21:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Wu Xiaobin | Officer | SELL | $261.20 | 626 | $163,512 | 0 |
| 2026-06-15 21:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Rosenberg Aaron | Officer | SELL | $257.74 | 631 | $162,637 | 0 |
| 2026-06-15 21:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Wang Lai | Officer | SELL | $261.00 | 756 | $197,318 | 0 |
| 2026-06-15 21:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Ball Titus B. | Officer | SELL | $257.20 | 169 | $43,467 | 0 |
| 2026-06-15 22:04 | 2026-06-12 | NATR | NATURES SUNSHINE PRODUCTS INC | Herbert Kevin R. | Officer | SELL | $20.68 | 2,000 | $41,364 | 48,866 |
| 2026-06-15 21:37 | 2026-06-11 | CRVO | CervoMed Inc. | BOGER JOSHUA S | Director, 10% owner | BUY | $3.14 | 955,414 | $3,000,000 | 1,795,865 |
| 2026-06-15 21:27 | 2026-06-11 | PBLS | Parabilis Medicines, Inc. | SEBULSKY ALAN | Director | BUY | $20.00 | 12,500 | $250,000 | 12,500 |
| 2026-06-15 21:12 | 2026-06-11 | CRVS | Corvus Pharmaceuticals, Inc. | Moore David Scott | Director | BUY | $11.53 | 21,700 | $250,236 | 21,700 |
| 2026-06-15 20:40 | 2026-06-15 | CYTK | CYTOKINETICS INC | Blum Robert I | Director, Officer | SELL | $70.46 | 7,500 | $528,450 | 385,330 |
| 2026-06-15 20:30 | 2026-06-11 | LQDA | Liquidia Corp | Krepp Sarah | Officer | SELL | $70.28 | 24,880 | $1,748,527 | 121,863 |
| 2026-06-15 20:15 | 2026-06-11 | KROS | Keros Therapeutics, Inc. | Newton Charles W. | Director | SELL | $10.04 | 550 | $5,522 | 12,665 |
| 2026-06-15 20:01 | 2026-06-11 | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | Officer | OPT+S | $6.17 | 2,800 | $17,276 | 700,000 |
| 2026-06-15 14:31 | 2026-06-11 | SER | Serina Therapeutics, Inc. | WILSON KAREN J | Director | BUY | $1.76 | 10,100 | $17,750 | 10,100 |
| 2026-06-15 11:00 | 2026-06-12 | TNXP | Tonix Pharmaceuticals Holding Corp. | Taylor Carolyn E. | Director | BUY | $10.55 | 1,415 | $14,928 | 1,833 |
| 2026-06-15 10:15 | 2026-05-13 | GDTC | CytoMed Therapeutics Ltd | Choo Chee Kong | Director, 10% owner | BUY | $1.15 | 112,000 | $128,778 | 430,324 |
| 2026-06-12 20:36 | 2026-06-11 | ORKA | Oruka Therapeutics, Inc. | Dambkowski Carl | Director | SELL | $70.13 | 35,000 | $2,454,382 | 38,743 |
| 2026-06-12 20:10 | 2026-06-11 | INDV | Indivior Pharmaceuticals, Inc. | Heidbreder Christian | Officer | SELL | $38.06 | 18,586 | $707,383 | 227,923 |
| 2026-06-12 20:28 | 2026-06-11 | CMND | Clearmind Medicine Inc. | HRT FINANCIAL LP | 10% owner | SELL | $0.12 | 225,191 | $27,698 | 1,838,075 |
| 2026-06-12 20:28 | 2026-06-10 | CMND | Clearmind Medicine Inc. | HRT FINANCIAL LP | 10% owner | BUY | $0.15 | 2,159,052 | $330,335 | 2,063,266 |
| 2026-06-12 20:14 | 2026-06-10 | JAZZ | Jazz Pharmaceuticals plc | Patil Neena M | Officer | SELL | $231.83 | 1,200 | $278,196 | 51,549 |
| 2026-06-13 01:07 | 2026-06-11 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | Officer | SELL | $23.50 | 6,115 | $143,703 | 62,284 |
| 2026-06-13 00:06 | 2026-06-12 | SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Officer | OPT+S | $10.00 | 25,000 | $250,000 | 12,176 |
| 2026-06-13 00:04 | 2026-06-12 | ALKS | Alkermes plc. | Wright Christopher I | Director | SELL | $45.10 | 2,000 | $90,200 | 25,680 |
| 2026-06-13 00:04 | 2026-06-12 | SPRY | ARS Pharmaceuticals, Inc. | Fitzpatrick Alexander A | Officer | SELL | $10.00 | 3,355 | $33,550 | 90,910 |
| 2026-06-12 22:38 | 2026-06-10 | CYRX | Cryoport, Inc. | ZECCHINI EDWARD J | Officer | OPT+S | $14.50 | 35,000 | $507,563 | 109,719 |
| 2026-06-12 22:13 | 2026-06-11 | QURE | uniQure N.V. | Meek David D. | Director | SELL | $27.06 | 1,993 | $53,931 | 39,747 |
| 2026-06-12 21:55 | 2026-06-11 | QURE | uniQure N.V. | O'Keefe Kylie | Officer | SELL | $27.06 | 15,936 | $431,228 | 108,864 |
| 2026-06-12 21:59 | 2026-06-11 | PRTA | PROTHENA CORP PUBLIC LTD CO | SCULLY WILLIAM P | 10% owner | BUY | $8.17 | 125,000 | $1,021,225 | 1,061,000 |
| 2026-06-12 22:04 | 2026-06-10 | QURE | uniQure N.V. | Gut Robert | Director | OPT+S | $26.32 | 10,278 | $270,485 | 32,259 |
| 2026-06-12 22:04 | 2026-06-10 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Officer | OPT+S | $24.20 | 8,519 | $206,151 | 63,443 |
| 2026-06-12 21:38 | 2026-06-11 | QURE | uniQure N.V. | POST LEONARD E | Director | SELL | $27.06 | 1,993 | $53,931 | 35,494 |
| 2026-06-12 21:45 | 2026-06-11 | QURE | uniQure N.V. | Springhorn Jeremy P. | Director | SELL | $27.06 | 1,993 | $53,931 | 43,251 |
| 2026-06-12 21:23 | 2026-06-11 | JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | Officer | OPT+S | $241.15 | 10,000 | $2,411,500 | 114,288 |
| 2026-06-12 21:25 | 2026-06-11 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $549.23 | 9,500 | $5,217,684 | 40,513 |
| 2026-06-12 21:26 | 2026-06-11 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | Officer | OPT+S | $549.29 | 10,000 | $5,492,894 | 18,876 |
| 2026-06-12 21:26 | 2026-06-10 | LGND | LIGAND PHARMACEUTICALS INC | LAMATTINA JOHN L | Director | SELL | $250.88 | 4,591 | $1,151,774 | 26,969 |
| 2026-06-12 21:27 | 2026-06-10 | LGND | LIGAND PHARMACEUTICALS INC | Aryeh Jason | Director | SELL | $250.00 | 5,000 | $1,250,000 | 102,580 |
| 2026-06-12 21:30 | 2026-06-10 | PTCT | PTC THERAPEUTICS, INC. | Pauwels Eric | Officer | OPT+S | $75.00 | 21,277 | $1,595,775 | 73,411 |
| 2026-06-12 21:30 | 2026-06-11 | QURE | uniQure N.V. | Kaye Jack | Director | SELL | $27.06 | 1,993 | $53,931 | 25,996 |
| 2026-06-12 21:08 | 2026-06-11 | QURE | uniQure N.V. | Balachandran Madhavan | Director | SELL | $27.06 | 1,993 | $53,931 | 43,254 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.